Food and Nutraceuticals are an evolving market and companies have the primary challenge of generating relevant scientific evidence to prove the safety and efficacy of different natural products that have potential health benefits for disease treatment and disease prevention. Techsol has helped key players in this segment to determine the right dose, study drug interaction, nutraceutical-drug interaction, and their effects on individuals under certain health conditions.

Common challenges with Nutraceutical Clinical trials

  • Larger sample sizes
  • Very difficult to pick an end-point
  • Often a need to do a pilot study to gain insight into desired end results
  • Harder to recruit for and have higher drop-out rates than pharmaceutical trials

How We Help Clients

Techsol has highly experienced functional teams to conduct nutraceutical trials, right from the study design to commercialization. With our expert team we provide the following services:

  • Study Protocol design
  • Sample Size Calculation
  • Study Database / electronic case report form (eCRF) Design
  • Identification of Primary and secondary data points that are ideal for statistical calculations
  • End-to-end Clinical Trial Management
  • Subject Recruitment and Retention strategies
  • Study Data Management
  • Clinical Data Statistical Analysis
  • Preparation and Submission of Final Clinical Study Reports
Work

We have the domain expertise and professional experience for end-to-end trial management, patient recruitment and retention, meeting trial timelines, budget, quality and compliance.

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Let Us Know How We Can Help You